welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
healthcare providers
Frank A. Sinicrope, MD
Healthcare Provider Professor of Oncology, Medicine
Mayo Clinic Rochester
200 1st St SW
Places : Mayo Clinic Dana-Farber Cancer Institute
Interests:
Colorectal cancer prevention and therapy of established disease
Education:
Fellowship: Medical Oncology, University of Texas M.D. Anderson Cancer Center
Fellowship: Gastroenterology, National Institutes of Health Research Fellow, University of Chicago
Fellowship: Gastroenterology/Hepatology, University of Chicago Hospitals
MD: University of Chicago Pritzker School of Medicine
Representative Publications:
Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients
expertly curated content related to this topic
- Chemoprevention of Colorectal Cancer: Systematic Review and Economic EvaluationBACKGROUND : Colorectal cancer (CRC) is ...
- Impact of a Hospital-based Register on the Management of Familial Adenomatous PolyposisColorectal cancer in familial adenomatou...
- A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)The purpose of this phase III study is t...
- Arupa Ganguly, PhDArupa Ganguly, PhD is Professor of Genet...
- Uri Ladabaum, MDUri Ladabaum, MD is a Professor of Medic...
- Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)To test whether celecoxib can be used to...
- Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)The purpose of this randomized, double-b...
English
Portuguese
Spanish